A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)

PHASE4CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Aortic DisordersCarotid DiseasePulmonary DiseasePeripheral Artery Disease
Interventions
OTHER

Iomeron

Iomeron or Imeron which is a iomeprol injection, hereafter referred to as iomeprol is an injectable solution of iomeprol, a non-ionic hydrosoluble iodinated compound used as a medical imaging contrast agent for radiological examinations.

Trial Locations (5)

110004

Shengjing Hospital of China Medical University, Shenyang

230601

The Second Hospital of Anhui Medical University, Hefei

430022

Wuhan Union Hospital, Wuhan

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Shanxi Province

830054

The First Teaching Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
collaborator

Bracco International B.V.

UNKNOWN

collaborator

Clinipace Worldwide

INDUSTRY

lead

Bracco Diagnostics, Inc

INDUSTRY